Physician profile
William A Morowitz
NPI 1144289315
$2,309.98
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,030 · 2020: $343 · 2021: $908 · 2022: $29.82.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $851.55 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $410.06 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $241.82 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $146.25 | 2019-2022 | |
| Mylan Specialty L.P. | $133.29 | 2019-2021 | |
| Philips North America LLC | $130.25 | 2019-2021 | |
| Insmed, INC. | $86.87 | 2019-2021 | |
| Electromed, INC. | $80.76 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $40.97 | 2020-2021 | |
| Genentech USA, INC. | $33.64 | 2019 | |
| Sunovion Pharmaceuticals INC. | $29.78 | 2019 | |
| Grifols USA, LLC | $29.67 | 2019-2021 | |
| United Therapeutics Corporation | $17.28 | 2021 | |
| Shire North American Group INC | $14.97 | 2019 | |
| Nabriva Therapeutics, Plc | $14.24 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Circassia INC. | $12.92 | 2019 | |
| Harmony Biosciences LLC | $12.32 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $12.23 | 2021 | |
| Merck Sharp & Dohme LLC | $11.11 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Morowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.